Matthias C Schmidt

A mechanistic classification of clinical phenotypes in neuroblastoma

F. Westermann, F. Berthold, Roman K. Thomas, 2018, Science.

German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients

W. Brenner, K. Rahbar, F. Mottaghy, 2017, Journal of Nuclear Medicine.

2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors

Vikas Prasad, Barbara Hero, Frank Berthold, 2017, Klinische Pädiatrie.

MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis

B. Hero, R. Versteeg, H. Caron, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project.

B. Hero, H. Brisse, K. Matthay, 2011, Radiology.

Neuroblastoma stage 4S with 123I‐MIBG‐positive bone marrow involvement

B. Hero, Matthias C Schmidt, A. Claviez, 2006, Pediatric blood & cancer.

EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy

M. Luster, A. Piccardo, Matthias C Schmidt, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[18F]-Fluorodeoxyglucose-Positron Emission Tomography for the Assessment of Histopathologic Response and Prognosis After Completion of Neoadjuvant Chemoradiation in Esophageal Cancer

A. Hölscher, S. Baldus, S. Mönig, 2009, Annals of surgery.

Radioiodtherapie bei benignen Schilddrüsenerkrankungen (Version 5)*

M. Luster, M. Dietlein, Matthias C Schmidt, 2016, Nuklearmedizin.